[LGND] QoQ Quarter Result on 30-Jun-2018 [#Q2]

Stock
[LGND] Ligand Pharmaceuticals Incorporated
Announcement Date
08-Aug-2018
Financial Year
2018
Quarter
30-Jun-2018 [#Q2]
Profit Trend
QoQ- 61.58%
YoY- 1,107.66%
Quarter Report
LGND's Result
LGND's Financial Summary
View:
Show?
Quarter Result
31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 CAGR
Revenue 43,484 59,590 45,663 90,043 56,157 50,464 33,375 19.30%
PBT 842,713 -56,789 79,226 95,579 55,312 30,665 12,071 1599.86%
Tax 176,376 -14,307 11,864 22,419 10,033 37,675 3,645 1231.03%
NP 666,337 -42,482 67,362 73,160 45,279 -7,010 8,426 1747.30%
Tax Rate -20.93% - -14.97% -23.46% -18.14% -122.86% -30.20% -
Total Cost -622,853 102,072 -21,699 16,883 10,878 57,474 24,949 -
Ratio Analysis
31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 CAGR
NP Margin 1,532.37 -71.29 147.52 81.25 80.63 -13.89 25.25 1448.17%
Per Share
31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 CAGR
EPS 32.59 -2.02 3.19 3.45 2.13 -0.34 0.40 1784.43%
EPS Diluted 31.32 -2.02 2.80 2.99 1.83 -0.33 0.36 1868.76%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.